1-7 of 7
R. Martinez
Close
Sort by
Journal Articles

Jak2 V617F Reversible Activation Shows an Essential Requirement for Jak2 V617F in Myeloproliferative Neoplasms (MPNs)

Andrew Dunbar, Robert L. Bowman, Young Park, Franco Izzo, Robert M. Myers, Abdul Karzai, Won Jun Kim, Inés Fernández Maestre, Michael R. Waarts, Abbas Nazir, Wenbin Xiao, Max Brodsky, Mirko Farina, Louise Cai, Sheng F Cai, Benjamin Wang, Wenbin An, Julie Yang, Shoron Mowla, Shira E. Eisman, Tanmay Mishra, Remie Houston, Emily Guzzardi, Anthony R. Martinez Benitez, Aaron D Viny, Richard Koche, Dan A. Landau, Ross L. Levine
Journal: Blood
Blood (2022) 140 (Supplement 1): 803–804.
https://doi.org/10.1182/blood-2022-164827
Published: 2022
Journal Articles

The Second Generation Type II JAK2 Inhibitor, AJ1-10502, Demonstrates Enhanced Selectivity, Improved Therapeutic Efficacy and Reduced Mutant Cell Fraction Compared to Type I JAK2 Inhibitors in Models of Myeloproliferative Neoplasms (MPNs)

Shivam Rai, Jan Stetka, MARC Usart, Hui Hao-Shen, Young Park, Remie Houston, Anthony R. Martinez Benitez, Matthew Wereski, Emily Guzzardi, Sonali Persaud, Hailey Ramzan, Alan Futran, Charley Xu, Jeremy Greenwood, Sayan Mondal, Craig Masse, Ross L. Levine, Radek C. Skoda, Andrew Dunbar
Journal: Blood
Blood (2022) 140 (Supplement 1): 6722–6723.
https://doi.org/10.1182/blood-2022-162621
Published: 2022
Journal Articles

TSLP-Induced Alterations of Multiple Signaling Pathways in Primary CRLF2 B-ALL Xenografts

Parveen Shiraz, MD, Olivia Francis, MS, Ineavely Delgado, BS, Shannalee R Martinez, BS, Jacqueline Coats, MS, Katherine Salcedo Conception, BS, Karina Mayagoitia, Elizabeth Ginelli, Terry-Ann Milford, MS, Ross Fisher, MD, Christopher L. Morris, MD PhD, Xiao-bing Zhang, PhD, Ruijun Su, MD PhD, Sinisa Dovat, MD,PhD, Kimberly J Payne, PhD
Journal: Blood
Blood (2014) 124 (21): 3783.
https://doi.org/10.1182/blood.V124.21.3783.3783
Published: 2014
Journal Articles

Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

Cathy A. Swindlehurst, PhD, Leah Fung, PhD, Kyle W.H. Chan, PhD, Sabine Ottilie, PhD, Ashkan Shahbandi, Christopher L. Morris, MD, PhD, Oliva L Francis, Terrence Bennet, Shannalee R Martinez, Kimberly J Payne, PhD
Journal: Blood
Blood (2011) 118 (21): 2590.
https://doi.org/10.1182/blood.V118.21.2590.2590
Published: 2011
Journal Articles

Rearrangement Patterns of Igs and bcl2/IgH and Clinical Significance in Follicular Lymphoma.

J. Martinez-Lopez, A. Rivero, Ph, C. Montalban, J. de la Serna, A. Fernandez-Sevilla, J. Paz, M. Canales, R. Ona, P. Sanchez-Godoy, R. Martinez, S. Grande, Ph, P. Martinez-Sanchez, Ph, R. Ayala, Jose F. Tomas
Journal: Blood
Blood (2006) 108 (11): 4629.
https://doi.org/10.1182/blood.V108.11.4629.4629
Published: 2006
Journal Articles

Influence of Age on Survival after a Tandem Hematopoietic Stem Cell Transplantation Procedure in Patients with Multiple Myeloma: Results of the Prospective GEM-2000 Protocol.

A. Sureda, J. Blade, J.J. Lahuerta, J. de la Rubia, R. Martinez, D. Carrera, J. Garcia-Laraña, A. Alegre, M. Hernandez, C. Rivas, J.M. Ribera, M.J. Peñarrubia, L. Palomera, F. Prosper, F. de Arriba, A. Leon, E. Abella, B. Hernandez-Ruiz, F. Casado, J.C. Garcia-Ruiz, J. Besalduch, F.J. Fernandez-Calvo, A. Touchard, J. San Miguel, for the Spanish Group of Multiple Myeloma (MM)
Journal: Blood
Blood (2004) 104 (11): 930.
https://doi.org/10.1182/blood.V104.11.930.930
Published: 2004
Journal Articles

A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element

D Perrotti, T Bellon, R Trotta, R Martinez, B Calabretta
Journal: Blood
Blood (1996) 88 (9): 3336–3348.
https://doi.org/10.1182/blood.V88.9.3336.bloodjournal8893336
Published: 1996